Design and implementation of an automated partial volume correction in PET: Application to dopamine receptor quantification in the normal human striatum

Journal of Nuclear Medicine

Volumn 49, Issue 7, 2008, Pages 1097-1106

  Rousset, Olivier G ^a,d   Collins, D Louis ^b   Rahmim, Arman ^a   Wong, Dean F ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

3D ROI; Automatic algorithm; Partial volume correction; PET; Striatum

Indexed keywords

DOPAMINE RECEPTOR; RACLOPRIDE C 11;

ADULT; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MATHEMATICAL MODEL; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; ALGORITHMS; CARBON ISOTOPES; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE;

EID: 46749142957     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048330     Document Type: Article

References (32)

1. Rousset OG, Zaidi H. Correction for partial volume effects in emission tomography. In: Quantitative Analysis in Nuclear Medicine Imaging. New York, NY: Springer Science + Business Media Inc.; 2005:236-271.
2. Kuwert T, Ganslandt T, Jansen P, et al. Influence of size of regions of interest on PET evaluation of caudate glucose consumption. J Comput Assist Tomogr. 1992; 16:789-794.
3. Rubins DJ, Melega WP, Lacan G, et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. NeuroImage. 2003;20:2100-2118.
4. Greer PJ, Villemagne VL, Ruszkiewicz J, et al. MR atlas of the baboon brain for functional neuroimaging. Brain Res Bull. 2002;58:429-438.
5. Kang KW, Lee DS, Cho JH, et al. Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probability brain atlas. NeuroImage. 2001;14:1-6.
6. Yasuno F, Hasnine AH, Suhara T, et al. Template-based method for multiple volumes of interest of human brain PET images. NeuroImage. 2002;16:577-586.
7. Svarer C, Madsen K, Hasselbalch SG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. NeuroImage. 2005;24:969-979.
8. Collins DL, Zijdenbos AP, Baare WFC, Evans AC. ANIMAL+INSECT: improved cortical structure segmentation. Lect Notes Comput Sci. 1999;1613:210-223.
9. Frouin V, Comtat C, Reilhac A, Grégoire M-C. Correction of partial volume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715-1726.
10. Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904-911.
11. Levant B. Receptor binding and quantitative autoradiographic studies. In: Wang JQ, ed. Drug of Abuse: Neurological Studies and Protocols. Totowa, NJ: Humana Press; 2002:297-314. Methods of Molecular Medicine Series.
12. Collins DL, Holmes CJ, Peters TM, Evans AC. Automatic 3D model-based neuroanatomical segmentation. Hum Brain Mapp. 1995;3:190-208.
13. Zijdenbos A, Forghani R, Evans A. Automatic quantification of MS lesions in 3D MRI brain data sets: validation of INSECT. Medical Image Computing and Computer-Assisted Intervention - MICCAI'98. Lect Notes Comput Sci. 1998;1496:439-448.
14. Evans AC, Collins DL. A 305-member MRI-based stereotaxic atlas for CBF activation studies. J Nucl Med. 1993;34:70-71.
15. Pham DL, Prince JL. Adaptive fuzzy segmentation of magnetic resonance images. IEEE Trans Med Imaging. 1999;18:737-752.
16. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997;16:187-198.
17. Ma Y, Kamber M, Evans AC. 3D simulation of PET brain images using segmented MRI data and positron tomograph characteristics. Comput Med Imaging Graph. 1993;17:365-371.
18. Degrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med. 1994;35:1398-1406.
19. Colsher JG. Fully three-dimensional positron emission tomography. Phys Med Biol. 1980;25:103-115.
20. Kessler RM, Ellis JR, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr. 1984;8:514-522.
21. 18F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Synapse. 2000;37:81-89.
22. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage. 1996;4:153-158.
23. Innis RC, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539.
24. Daube-Witherspoon M, Carson R. Axial slice width in 3D PET: characterization and potential improvement with axial interleaving. Phys Med Biol. 1998;43:921-928.
25. Strul D, Slates RB, Dahlbom M, Cherry SR, Marsden PK. An improved analytical detector response function model for multilayer small-diameter PET scanners. Phys Med Biol. 2003;48:979-994.
26. Zaidi H, Ruest T, Schoenahl F, Montandon M-L. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. NeuroImage. 2006;32:1591-1607.
27. Toga AW, Thompson PM. Brain atlases of normal and diseased populations. Int Rev Neurobiol. 2005;66:1-54.
28. Smith S, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(suppl 1):S208-S219.
29. Duchesne S, Pruessner JC, Collins DL. Appearance-based segmentation of medial temporal lobe structures. NeuroImage. 2002;17:515-531.
30. Carmichael OT, Aizenstein HA, Davis SW, et al. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. NeuroImage. 2005;27:979-990.
31. Volkow ND, Wang GJ, Fowler JS, et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse. 2002;44:175-180.
32. Aalto S, Hirvoven J, Kajander J, et al. Ketamine does not decrease striatal dopamine D2 receptor binding in man. Psychopharmacology (Berl). 2002;164:401-406.